AlpInvest Partners B.V. Purchases Shares of 36,504 Heartflow, Inc. $HTFL

Key Points

• AlpInvest Partners purchased 36,504 Heartflow shares worth approximately $1.07 million in the second quarter, making HTFL its 13th-largest holding and representing about 1.8% of its portfolio.
• Analyst sentiment is broadly positive, with a consensus “Moderate Buy” rating and an average price target of $43.43; several firms recently raised targets to $45.
• Heartflow reported quarterly revenue of $64.08 million, up 47.7% year over year, and an adjusted loss of $0.07 per share that beat estimates. However, CEO John C.M. Farquhar sold 15,560 shares for about $608,000 under a pre-arranged trading plan.

AlpInvest Partners B.V. purchased a new position in Heartflow, Inc. (NASDAQ:HTFL - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 36,504 shares of the company's stock, valued at approximately $1,071,000. Heartflow makes up about 1.8% of AlpInvest Partners B.V.'s portfolio, making the stock its 13th largest holding.

Several other hedge funds have also modified their holdings of HTFL. TrueMark Investments LLC grew its position in shares of Heartflow by 1.4% during the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company's stock worth $654,000 after buying an additional 379 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Heartflow in the fourth quarter worth approximately $27,000. Strs Ohio lifted its stake in Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company's stock worth $112,000 after acquiring an additional 1,200 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in Heartflow during the 4th quarter worth approximately $45,000. Finally, Legal & General Group Plc purchased a new stake in shares of Heartflow in the 3rd quarter valued at approximately $59,000.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Robert W. Baird set a $45.00 price objective on shares of Heartflow in a report on Friday. Freedom Capital raised Heartflow to a "strong-buy" rating in a report on Tuesday, June 30th. Stifel Nicolaus raised their price target on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Friday, August 14th. Benchmark reaffirmed a "buy" rating on shares of Heartflow in a report on Friday. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $45.00 price objective (up from $38.00) on shares of Heartflow in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Heartflow currently has a consensus rating of "Moderate Buy" and a consensus target price of $43.43.

Insider Buying and Selling at Heartflow

In related news, CEO John C.M. Farquhar sold 15,560 shares of the company's stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $39.06, for a total value of $607,773.60. Following the completion of the sale, the chief executive officer directly owned 420,720 shares of the company's stock, valued at $16,433,323.20. This represents a 3.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 122,146 shares of company stock valued at $3,877,116. 7.70% of the stock is currently owned by insiders.

Heartflow Price Performance

Shares of NASDAQ:HTFL opened at $45.23 on Wednesday. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $45.33. The firm has a market capitalization of $3.90 billion and a P/E ratio of -24.72. The company's fifty day moving average price is $29.68 and its 200 day moving average price is $27.95.

Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.50%. The business's revenue was up 47.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current year.

About Heartflow

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source